The endocrine system in Covid-19 experiencing monitoring A multi-center study of Pakistan

SARS-CoV-2 (SARS-CoV-2) is a new coronavirus that surfaced in December 2019 and is accountable for a pandemic. A wide range of clinical manifestations, ranging from the absence of symptoms to multisystem organ failure due to hypoxaemic acute respiratory syndrome, are recorded. Coronavirus illness 2019's effect on endocrine glands is not yet clear. To help patients with chronic endocrine illnesses, we may draw on prior research on viruses in the same family to provide treatment options. Treatment for SARS-CoV-2 must not be halted if these patients are infected. Hormone replacement therapy dosages may need to be raised in certain circumstances. Hormonal biological surveillance is required in the event of deteriorating clinical symptoms. This article will assist improve the treatment of chronic endocrine illnesses that might impair thyroid, adrenal, gonad, and pituitary gland activities. Subjects infected with COVID-19 or those in touch with COVID-19-infected individuals might be studied using these ideas.